Introduction/Objective. Invasive candidiasis (IC) is the most common invasive
fungal infection in humans. It manifests as candidemia, and can affect
internal organs and lead to sepsis and septic shock. A good knowledge of the
factors that lead to the morbidity and mortality of these patients is
necessary. We aimed to investigate the factors associated with the
unfavorable outcome of patients with IC treated in our institution.
Methods. The research was conducted at the Military Medical Academy in
Belgrade, Serbia. The retrospective cohort study included 145 patients of
both sexes, aged over 18 years, with a proven diagnosis of invasive
candidiasis. Demographics, comorbidities, use of therapeutic procedures,
antibiotics, antifungal treatment and outcome were compared between deceased
and surviving patients with invasive candidiasis. The results were analyzed
using Student's t-test, Mann-Whitney U test, multivariate statistical
analysis. Results. The results showed that the predictors of death were DM
(adjusted OR 6.886; CI 2.608-18.178; p = 0.000) and chemotherapy (adjusted
OR 6.826; 95% CI: 2.037-22.866; p = 0.002), which increase the risk for
death seven times compared to the basal risk and mechanical ventilation,
which increases the risk of death about three times (adjusted OR: 3.056; 95%
CI: 1.132-8.253; p = 0.012). Conclusion. Optimal treatment is necessary in
terms of early detection and identification of the causative agent of IC. In
susceptible patients, such as immunocompromised patients, appropriate
treatment should be initiated as soon as possible.